The Oral Biologics & Biosimilars Global Market Report 2023, provides comprehensive information on the oral biologics & biosimilars market across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa for the 27 major global industries. The report covers a ten year historic period – 2010-2021, and a ten year forecast period – 2023-2032.
Learn More On The Oral Biologics & Biosimilars Market’s Growth:
As per The Business Research Company’s Oral Biologics & Biosimilars Global Market Report 2023, the global oral biologics and biosimilars market size will grow from $5.37 billion in 2022 to $6.47 billion in 2023 at a compound annual growth rate (CAGR) of 20.3%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of oral biologics and biosimilars is expected to grow from $13.68 billion in 2027 at a CAGR of 20.6%.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=6830&type=smp
The oral biologics & biosimilars market is segmented:
1) By Therapy: Lymphocyte Modulators, Interleukin Inhibitors, and Tumor Necrosis Factor-Alpha Inhibitors
2) By Disease: Asthma, Crohn’s Disease, Carcinoma, Arthritis, Diabetes, Multiple Myeloma, Enterocolitis, Multiple Sclerosis, Sarcoma, Psoriasis and Other Diseases
3) By Molecule Type: Vaccines, Proteins and Peptides, Monoclonal Antibodies, and Other Molecule Types
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies
North America was the largest region in the oral biologics & biosimilars market in 2022.
The table of contents in TBRC’s oral biologics & biosimilars market report includes:
- Executive Summary
- Oral Biologics & Biosimilars Market Characteristics
- Oral Biologics & Biosimilars Market Trends And Strategies
- Impact Of COVID-19 On Oral Biologics & Biosimilars
- Oral Biologics & Biosimilars Market Size And Growth
- Oral Biologics & Biosimilars Market Segmentation
- Oral Biologics & Biosimilars Market Regional And Country Analysis
.
.
.
- Oral Biologics & Biosimilars Market Competitive Landscape And Company Profiles
- Oral Biologics & Biosimilars Pipeline Analysis
- Key Mergers And Acquisitions In The Oral Biologics & Biosimilars Market
Learn About Us:
The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries. Through the report businesses can gain a thorough understanding of the market’s size, growth rate, major drivers and leading players.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
